These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 7928264)

  • 1. Magnetization transfer contrast in gadopentetate-dimeglumine-enhanced breast magnetic resonance imaging at 0.1 Tesla.
    Dean KI; Komu M; Dean PB; Kormano M
    Invest Radiol; 1994 Jun; 29 Suppl 2():S302-3. PubMed ID: 7928264
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine.
    Heywang-Köbrunner SH; Haustein J; Pohl C; Beck R; Lommatzsch B; Untch M; Nathrath WB
    Radiology; 1994 Jun; 191(3):639-46. PubMed ID: 8184040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative dynamic contrast breast-MRI with the 0.5 tesla equipment].
    Klengel S; Hietschold V; Schreiber M; Köhler K
    Rontgenpraxis; 1994 Aug; 47(8):223-8. PubMed ID: 7974011
    [No Abstract]   [Full Text] [Related]  

  • 4. Three-dimensional gadolinium-enhanced MR imaging of the breast: pulse sequence with fat suppression and magnetization transfer contrast. Work in progress.
    Pierce WB; Harms SE; Flamig DP; Griffey RH; Evans WP; Hagans JE
    Radiology; 1991 Dec; 181(3):757-63. PubMed ID: 1947093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gadopentetate-dimeglumine-enhanced magnetic resonance imaging for lung nodules. Differentiation of lung cancer and tuberculoma.
    Kusumoto M; Kono M; Adachi S; Yamasaki K; Itouji E; Sakai E; Endo M; Nakamura T; Kimura K
    Invest Radiol; 1994 Jun; 29 Suppl 2():S255-6. PubMed ID: 7928249
    [No Abstract]   [Full Text] [Related]  

  • 6. Gadopentetate dimeglumine-enhanced MR imaging of subdural hematoma in an abused infant.
    Kleinman PK; Ragland RL
    AJR Am J Roentgenol; 1996 Jun; 166(6):1456-8. PubMed ID: 8633463
    [No Abstract]   [Full Text] [Related]  

  • 7. Breast neoplasms: T2* susceptibility-contrast, first-pass perfusion MR imaging.
    Kuhl CK; Bieling H; Gieseke J; Ebel T; Mielcarek P; Far F; Folkers P; Elevelt A; Schild HH
    Radiology; 1997 Jan; 202(1):87-95. PubMed ID: 8988196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anaphylactoid reaction caused by intravenous gadopentetate dimeglumine in magnetic resonance].
    Campos A; Aznar L; Alamar R; Castelló JV
    Med Clin (Barc); 1996 Feb; 106(5):197. PubMed ID: 8684023
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of gadopentetate dimeglumine on proton magnetization transfer in protein solutions and tissues at 0.1 Tesla.
    Kormano M; Komu M; Niemi P; Virta A
    Invest Radiol; 1994 Jun; 29 Suppl 2():S247-8. PubMed ID: 7523328
    [No Abstract]   [Full Text] [Related]  

  • 10. Fatal reaction to gadopentetate dimeglumine.
    Jordan RM; Mintz RD
    AJR Am J Roentgenol; 1995 Mar; 164(3):743-4. PubMed ID: 7863905
    [No Abstract]   [Full Text] [Related]  

  • 11. Definition of peritumoral vessels with contrast-enhanced magnetic resonance imaging: comparison of gadopentetate dimeglumine and a blood-pool macromolecular contrast medium.
    Brasch RC; Schwickert HC; Roberts TP; Shames DM; van Dijke CF; Mann JS; Demsar F
    Acad Radiol; 1996 Aug; 3 Suppl 2():S464-5. PubMed ID: 8796630
    [No Abstract]   [Full Text] [Related]  

  • 12. The variability of fibroadenoma in contrast-enhanced dynamic MR mammography.
    Brinck U; Fischer U; Korabiowska M; Jutrowski M; Schauer A; Grabbe E
    AJR Am J Roentgenol; 1997 May; 168(5):1331-4. PubMed ID: 9129437
    [No Abstract]   [Full Text] [Related]  

  • 13. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique.
    Boetes C; Barentsz JO; Mus RD; van der Sluis RF; van Erning LJ; Hendriks JH; Holland R; Ruys SH
    Radiology; 1994 Dec; 193(3):777-81. PubMed ID: 7972823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of a previous allergy to an iodinated contrast agent in the administration of gadopentetate dimeglumine.
    García N; Ramón E; Gonzalez del Valle L; Ruano M; Jiménez E
    Ann Pharmacother; 1997 Mar; 31(3):374. PubMed ID: 9066954
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
    Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW
    AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety review of gadopentetate dimeglumine. Extended clinical experience after more than five million applications.
    Niendorf HP; Alhassan A; Geens VR; Clauss W
    Invest Radiol; 1994 Jun; 29 Suppl 2():S179-82. PubMed ID: 7928222
    [No Abstract]   [Full Text] [Related]  

  • 17. Is there any role for gadopentetate dimeglumine administration when searching for mesial temporal sclerosis in patients with seizures?
    Bronen RA
    AJR Am J Roentgenol; 1995 Feb; 164(2):503. PubMed ID: 7839999
    [No Abstract]   [Full Text] [Related]  

  • 18. Technical note: magnetic resonance imaging-guided pre-operative breast localization using "freehand technique".
    Brenner RJ; Shellock FG; Rothman BJ; Giuliano A
    Br J Radiol; 1995 Oct; 68(814):1095-8. PubMed ID: 7496711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic MR mammography: a technique for potentially reducing the biopsy rate for benign breast disease.
    Turkat TJ; Klein BD; Polan RL; Richman RH
    J Magn Reson Imaging; 1994; 4(4):563-8. PubMed ID: 7949682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hepatocellular carcinoma with dynamic MR imaging during intraarterial infusion of gadopentetate dimeglumine.
    Fujita T; Ito K; Choji T; Honjo K; Matsumoto T; Arita T; Nakanishi T
    AJR Am J Roentgenol; 1994 Oct; 163(4):865-6. PubMed ID: 8092025
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.